Medication info
Pitasan Tablet 4 mg (Pitavastatin Calcium Hydrate)

Pitasan Tablet 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
Light yellow, round film-coated tablet
Packaging
Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202103533 · Approved 2021.04.30

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. The dose should be adjusted appropriately at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued treatment.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apo-B protein
  • triglyceride levels
View approved original text

This medication helps to control cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It specifically reduces total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing levels of HDL cholesterol, the good cholesterol. It improves blood lipid levels when used as an adjunct to dietary therapy, contributing to a reduced risk of cardiovascular disease. For these reasons, this drug is effectively used in the treatment of dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. The dose should be adjusted appropriately at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued treatment.

Precautions

This drug should not be used in patients with allergies to specific components or severe liver disease. It should also not be administered in cases of active liver disease or persistently elevated liver enzyme levels. Patients taking cyclosporine or with myopathy, pregnant women, women who may become pregnant, and breastfeeding women should not use this drug. There is no experience using this medication in pediatric patients, so it should not be administered to children. Patients with lactose intolerance or specific genetic conditions, as well as those allergic to soybean oil, beans, or peanuts, should also avoid this drug. Patients with renal function abnormalities or a history of liver disorders should use this medication with caution. Care should be taken, especially when taken with fibrates or niacin, as the risk of muscle damage increases. Patients who excessively consume alcohol should use this drug cautiously. Elderly patients, those with hypothyroidism, genetic muscle diseases, hyperlipidemia, diabetes, and severe myasthenia gravis also require caution. This drug can cause a variety of adverse reactions such as muscle pain, liver dysfunction, skin rashes, and digestive disturbances, so immediate consultation with a doctor is necessary if symptoms occur. Particularly, if muscle pain, weakness, or changes in urine color are observed, treatment should be discontinued due to the possibility of rhabdomyolysis. Regular liver function tests and blood lipid level assessments should be conducted before and during treatment to evaluate therapeutic efficacy. This drug is used for the treatment of hypercholesterolemia, and it is recommended to accompany dietary therapy and exercise. It should not be crushed or divided when taken, and must be kept out of reach of children. Pregnant or breastfeeding women should not take this drug, and if pregnancy is confirmed, treatment should be discontinued immediately. When taken with other medications, attention should be paid to interactions, especially avoiding co-administration with cyclosporine, fibrates, and niacin. Elderly patients may experience adverse effects due to decreased physical function, so dose adjustment and caution are necessary.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 76 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • increased bilirubin
  • elevated cholinesterase
  • increased AST
  • increased ALT
  • elevated γ-GT
  • increased ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • indigestion
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurry vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • skin tingling
  • loss of appetite
  • increased blood pressure
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container that blocks light, and the storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Light yellow, round film-coated tablet

Package unit

Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.